Re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol 2020;78:652-6: Can Mutant SPOP Become an Actionable Biomarker for Precision Oncology Management of Prostate Cancer?

Eur Urol. 2021 Mar;79(3):e91-e93. doi: 10.1016/j.eururo.2020.12.012. Epub 2020 Dec 25.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers
  • Castration
  • Humans
  • Male
  • Mutation
  • Nuclear Proteins
  • Precision Medicine*
  • Prostatic Neoplasms* / genetics
  • Repressor Proteins

Substances

  • Biomarkers
  • Nuclear Proteins
  • Repressor Proteins
  • SPOP protein, human